Canton Strategic Holdings Inc (CNTN)

Currency in USD
2.059
+0.119(+6.14%)
Real-time Data·
CNTN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.0002.120
52 wk Range
1.0819.080
Key Statistics
Prev. Close
1.94
Open
2
Day's Range
2-2.12
52 wk Range
1.081-9.08
Volume
431.09K
Average Volume (3m)
901.93K
1-Year Change
37.8849%
Book Value / Share
8.29
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CNTN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Earnings

Latest Release
May 13, 2026
EPS / Forecast
-0.23 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CNTN Income Statement

Compare CNTN to Peers and Sector

Metrics to compare
CNTN
Peers
Sector
Relationship
P/E Ratio
−2.0x−5.9x−0.4x
PEG Ratio
−0.020.740.00
Price/Book
0.3x1.9x2.6x
Price / LTM Sales
-15.6x2.9x
Upside (Analyst Target)
-417.2%58.0%
Fair Value Upside
Unlock−5.4%9.5%Unlock

Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States. It operates in two segments, Digital Asset Treasury and Clinical Stage Bio-technology. The company is involved in the operation of Canton Coin-centric digital asset treasury strategies, including validator operations and network participation; application support and strategic investments; collaboration and ecosystem advancement; capital raising and treasury expansion; token management - locking, lending, and options; Canton Foundation; and governance and risk management. It also researches and develops GV104, a buccal film formulation of nalmefene for the treatment of respiratory depression and prophylactic protection against synthetic opioid exposure in military and first responders; and GV023, an oral anti-tumor necrosis factor-alpha monoclonal antibody that addresses critical limitation of IV gold standard for the treatment of repeated intravenous infusions. The company was formerly known as Tharimmune, Inc. and changed its name to Canton Strategic Holdings, Inc. in February 2026. Canton Strategic Holdings, Inc. was incorporated in 2017 and is headquartered in Red Bank, New Jersey.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
9.53M12.36%18.49M
Other Institutional Investors
5.34M6.93%10.37M
Public Companies & Retail Investors
62.24M80.71%120.75M
Total
77.12M100.00%149.62M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
ARK Investment Management LLC4.74%3,657,5487,096
ARK Venture Fund4.22%3,252,0336,309

People Also Watch

5.92
LENZ
+8.03%
5.76
SPRY
-3.03%
35.25
BLKB
+7.77%
230.68
ERIE
+3.19%

FAQ

What Is the Canton Strategic Holdings (CNTN) Stock Price Today?

The Canton Strategic Holdings stock price today is 2.059 USD.

What Stock Exchange Does Canton Strategic Holdings Trade On?

Canton Strategic Holdings is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Canton Strategic Holdings?

The stock symbol for Canton Strategic Holdings is "CNTN."

What Is the Canton Strategic Holdings Market Cap?

As of today, Canton Strategic Holdings market cap is 149.620M USD.

What Is Canton Strategic Holdings's Earnings Per Share (TTM)?

The Canton Strategic Holdings EPS (TTM) is -1.425.

From a Technical Analysis Perspective, Is CNTN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Canton Strategic Holdings Stock Split?

Canton Strategic Holdings has split 2 times.

How Many Employees Does Canton Strategic Holdings Have?

Canton Strategic Holdings has 12 employees.

What is the current trading status of Canton Strategic Holdings (CNTN)?

As of Jul 27, 2026, Canton Strategic Holdings (CNTN) is trading at a price of 2.059 USD, with a previous close of 1.940 USD. The stock has fluctuated within a day range of 2.000 USD to 2.120 USD, while its 52-week range spans from 1.081 USD to 9.080 USD.

What Is the CNTN Premarket Price?

CNTN's last pre-market stock price is 2.030 USD. The pre-market share volume is 6,880.000, and the stock has decreased by 0.090, or 4.640%.

What Is the CNTN After Hours Price?

CNTN's last after hours stock price is 2.000 USD, the stock has decreased by 0.060, or 3.090%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.